Stocks and Investing Stocks and Investing
Thu, May 23, 2024

Hartaj Singh Maintained (VIRX) at Buy with Decreased Target to $11 on, May 23rd, 2024


Published on 2024-10-28 11:34:12 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy with Decreased Target from $13 to $11 on, May 23rd, 2024.

Hartaj has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Hartaj's Rating of Hold.



This is the rating of the analyst that currently disagrees with Hartaj


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Tuesday, April 16th, 2024
Contributing Sources